Botanical drug puerarin coordinates with nerve growth factor in the regulation of neuronal survival and neuritogenesis via activating ERK1/2 and PI3K/Akt signaling pathways in the neurite extension process

CNS Neurosci Ther. 2015 Jan;21(1):61-70. doi: 10.1111/cns.12334. Epub 2014 Oct 14.

Abstract

Aim: Nerve growth factor (NGF) regulates neuronal survival and differentiation by activating extracellular signal-regulated-kinases (ERK) 1/2 and phosphoinositide-3-kinase (PI3K)/Akt pathways in two distinct processes: latency process and neurite extension process. This study was designed to investigate whether botanical drug C-glucosylated isoflavone puerarin coordinates with NGF to regulate neuritogenesis via activating ERK1/2 and PI3K/Akt in neurite extension process.

Methods: We investigated the neuroprotective and neurotrophic activities of puerarin in MPTP-lesioned mice and dopaminergic PC12 cells. The effects of puerarin on ERK1/2, Akt, Nrf2, and HO-1 were assessed by Western blotting. The neurite outgrowth was assayed by neurite outgrowth staining kit.

Results: Puerarin protected dopaminergic cells and ameliorated the behavioral impairments in MPTP-lesioned mice. Puerarin potentiated the effect of NGF on neuritogenesis in PC12 cells by >10-fold. Mechanistic studies revealed: (1) puerarin rapidly activated ERK1/2 and Akt, leading to the activation of Nrf2/heme oxygenase-1 (HO-1) pathways; (2) ERK1/2, PI3K/Akt, and HO-1 inhibitors attenuated the neuritogenic activity of puerarin. Notably, puerarin enhanced NGF-induced neuritogenesis in a timing-dependent manner.

Conclusion: Puerarin effectively coordinated with NGF to stimulate neuritogenesis via activating ERK1/2 and PI3K/Akt pathways in neurite extension process. These results demonstrated a general mechanism supporting the therapeutic application of puerarin-related compounds in neurodegenerative diseases.

Keywords: ERK1/2; Neuritogenesis; Nrf2/heme oxygenase-1; PI3K/Akt; Puerarin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Animals
  • Cell Enlargement
  • Cell Survival / drug effects
  • Heme Oxygenase-1 / metabolism
  • Isoflavones / pharmacology*
  • MAP Kinase Signaling System / physiology
  • Male
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nerve Growth Factor / metabolism
  • Neurites / drug effects*
  • Neurites / physiology
  • Neurogenesis / drug effects*
  • Neurogenesis / physiology
  • Neurons / drug effects*
  • Neurons / physiology
  • Neuroprotective Agents / pharmacology*
  • PC12 Cells
  • Phosphatidylinositol 3-Kinases / metabolism
  • Random Allocation
  • Rats

Substances

  • Isoflavones
  • Membrane Proteins
  • Neuroprotective Agents
  • Nerve Growth Factor
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • Phosphatidylinositol 3-Kinases
  • puerarin